PROCEPT BioRobotics PRCT 深 滬
已收盤 10-31 16:00:00 美东时间
34.03
-0.350
-1.02%
華盛通- 最 高34.88
- 今 開34.88
- 成交量 102.16万股
- 最 低 33.68
- 昨 收 34.38
- 總市值 18.93亿
- 52周最高 103.8099
- 市盈率 靜 --
- 換手率 1.84%
- 52周最低 32.1101
- 委 比 99.42%
- 總股本 5563.59万
- 歷史最高 103.8099
- 量 比 0.75
- 振 幅 3.49%
- 歷史最低 15.38
- 每 手 1
- 風險率 18.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
10-16 10:43
Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock
Ratings for PROCEPT BioRobotics (NASDAQ:PRCT) were provided by 4 analysts in th...
10-16 06:00
Truist Securities Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $50
Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $64 to $50.
10-15 23:35
BTIG Reiterates Neutral on PROCEPT BioRoboticsto Neutral
BTIG analyst Ryan Zimmerman reiterates PROCEPT BioRobotics (NASDAQ:PRCT) from Neutral to Neutral.
09-16 18:28
Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts
Throughout the last three months, 4 analysts have evaluated PROCEPT BioRobotics...
09-03 05:00
Oppenheimer Upgrades PROCEPT BioRobotics to Outperform, Announces $60 Price Target
Oppenheimer analyst Suraj Kalia upgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Perform to Outperform and announces $60 price target.
09-02 20:22
PROCEPT BioRobotics shares are trading lower following the release of its Q2 financial results.
PROCEPT BioRobotics shares are trading lower following the release of its Q2 fi...
08-07 05:01
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Procept BioRobotics down after CEO retirement
Shares of Procept BioRobotics (NASDAQ:PRCT) fell ~9% on Friday after the surgical robotics company announced that its CEO, Reza Zadno, would retire effective Sept. 1, and Larry Wood, a member of the b...
07-25 23:23
PROCEPT BioRobotics Announces Preliminary Q2 Revenue Of ~$79.2M
SAN JOSE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (NASDAQ:PRCT) ("the Company"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology,
07-25 06:05
